F293-0465 Screening compound: 5-(4-methoxybenzenesulfonamido)-2-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]pyridine-3-carboxylic acid

F293-0465 Screening compound: 5-(4-methoxybenzenesulfonamido)-2-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]pyridine-3-carboxylic acid
F293-0465 Screening compound: 5-(4-methoxybenzenesulfonamido)-2-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]pyridine-3-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F293-0465
5-(4-methoxybenzenesulfonamido)-2-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]pyridine-3-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F293-0465

Molecular Formula

C25H28N4O5S (C25 H28 N4 O5 S)

Compound Name

5-(4-methoxybenzenesulfonamido)-2-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]pyridine-3-carboxylic acid

IUPAC name

5-(4-methoxybenzenesulfonamido)-2-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]pyridine-3-carboxylic acid

SMILES

CC(CN(CC1)c(c(C(O)=O)c2)ncc2NS(c(cc2)ccc2OC)(=O)=O)N1c1cc(C)ccc1

InChI

InChI=1S/C25H28N4O5S/c1-17-5-4-6-20(13-17)29-12-11-28(16-18(29)2)24-23(25(30)31)14-19(15-26-24)27-35(32,33)22-9-7-21(34-3)8-10-22/h4-10,13-15,18,27H,11-12,16H2,1-3H3,(H,30,31)

InChI Key

HMXSMJVIUONJFV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27112691

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

496.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.676

Distribution Coefficient, logD

3.068

Water Solubility, LogSw

-4.21

Polar Surface Area

91.842

Acid Dissociation Constant (pKa)

5.80

Base Dissociation Constant (pKb)

2.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.00

F293-0465 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F293-0465 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F293-0465?
Check Price and Availability of F293-0465, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F293-0465 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F293-0465
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F293-0465
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F293-0465 available by request